- Drug Name: Enjaymo
- Generic Name: Sutimlimab
- Dosage Forms and Strengths: Injection: 1,100 mg/22 mL single-dose vial
- Manufactured by: Bioverativ USA Inc.
To optimize Sutimlimab treatment outcomes, vaccination against encapsulated bacteria should be administered at least two weeks before commencing treatment. The dosage, personalized based on weight, involves a weekly application for the initial two weeks, followed by a biweekly schedule thereafter:
- Patients weighing 39 kg to less than 75 kg: 6,500 mg via intravenous infusion
- Patients weighing 75 kg or more: 7,500 mg via intravenous infusion.
All Trademarks and Brands that appear on the website belong to their respective owners and indianpharmanetwork does not lay any claim on them we only provide Information.